Beta-02 is developing the first implantable bio-artificial pancreas to address Type I diabetes and eliminate the need for insulin injections. This revolutionary device employs advanced technologies for protecting implanted pancreatic islet cells from destruction by the host immune system and supplying them with adequate oxygen and nutrients.
View Complete Profile
